Complications after Breast Surgery Are More Common in Obese Women
Risk is 12 Times Higher than in Nonobese Women, Study Reports
Arlington Heights, Ill. - Obese women are at substantially higher risk of complications following breast surgery, according to a study in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"Obesity is associated with a nearly twelve-fold increased odds of a postoperative complication after elective breast procedures," concludes the report by Catherine Lee Chen, MD and colleagues of The Johns Hopkins University School of Medicine, Baltimore. The results suggest that surgeon and hospital quality data should be adjusted to reflect the increased risks associated with surgery in obese patients.
Obesity Linked to Increased Complications of Breast Surgery
The researchers analyzed insurance claim data on approximately 8,000 women undergoing elective breast surgery between 2002 and 2006. Of the 8,000, 2,400 women (about 30 percent) were obese. For each type of procedure, rates and types of complications were compared for obese versus nonobese women.
Overall, about 18 percent of obese women filed an insurance claim covering a complication after breast surgery, compared to two percent of nonobese women. After adjustment for other factors, the risk of complications was 11.8 times higher for obese patients.
The difference was most pronounced for complications involving inflammation: more than 20 times greater than for nonobese women. Obese women were at higher risk of many other types of complications as well, including infection, pain and fluid collections (seroma or hematoma) after surgery.
Because the analysis was limited to procedures covered by health insurance, it did not include women undergoing aesthetic plastic surgery procedures, such as breast augmentation. More than 80 percent of the obese women in the study were undergoing breast reduction surgery, as did 64 percent of nonobese women. The next most common procedure was breast reconstruction, performed in 10 percent of obese women and 24 percent of nonobese women.
The obesity rate has risen rapidly in recent decades, to the point where 34 percent of U.S. adults are now estimated to be obese. "While the effect of obesity on disease has been established, its impact on short-term surgical outcomes has not been quantified," Dr. Chen and colleagues write.
Important Implications for Measuring Surgical Quality
In addition to its impact on patient health, the study may have important economic implications-especially with the movement toward "pay for performance" plans linking financial reimbursement to standardized health care quality metrics. The standard metrics currently used for measuring health care quality don't account for the possible increase in risk of complications in obese patients.
The new analysis provides evidence that obese women undergoing breast surgery are at greatly increased risk of complications. Even when other risk factors are taken into account, the complication rate is nearly 12 times higher for obese women. Researchers note that these excess complications could occur even though the doctor and hospital followed all recommended quality steps-for example, giving appropriate preventive antibiotics.
Dr. Chen and coauthors acknowledge some important limitations of their study-especially the fact that it was limited to patients undergoing procedures reimbursed by health insurance. They conclude, "As quality measures are increasingly applied to surgical evaluation and reimbursement, appropriate risk adjustment to account for the effect of obesity on outcomes will be essential."
Plastic and Reconstructive Surgery® is published by Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions and services for the clinicians, nurses, accountants, lawyers and tax, finance, audit, risk, compliance and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.